ONCOTHERAPY SCIENCE INC.

Research ONCOTHERAPY SCIENCE INC. (30O) on Bullrun: market cap EUR 29.10M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker30O
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 29.10M
• Financial periodFY2025
• RevenueEUR 750.05M
• Revenue growth22.9%
• Net income-EUR 815.29M
• Free cash flow-EUR 815.30M
• Gross margin-1.7%

Valuation Snapshot

latest market cap is EUR 29.10M.

About ONCOTHERAPY SCIENCE INC.

OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan. Its development pipeline includes OTS167, a small molecular compound that targets the maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer;

Frequently asked questions

What is ONCOTHERAPY SCIENCE INC.'s market cap?

ONCOTHERAPY SCIENCE INC.'s market capitalization is EUR 29.10M.

What does ONCOTHERAPY SCIENCE INC. do?

OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan.